neo-gambogic acid has been researched along with Colorectal Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Gong, Y; Gu, Y; Li, Y; Lu, Y; Wang, H; Wu, M | 1 |
Bi, Y; Guo, J; Liu, Y; Pan, L; Tan, Y; Yu, X; Zhao, Q; Zhong, J | 1 |
2 other study(ies) available for neo-gambogic acid and Colorectal Neoplasms
Article | Year |
---|---|
Neogambogic acid suppresses characteristics and growth of colorectal cancer stem cells by inhibition of DLK1 and Wnt/β-catenin pathway.
Topics: Apoptosis; beta Catenin; Calcium-Binding Proteins; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Glycogen Synthase Kinase 3 beta; Humans; Membrane Proteins; Neoplastic Stem Cells; Proliferating Cell Nuclear Antigen; Wnt Signaling Pathway; Xanthenes | 2022 |
Gambogenic acid induces Noxa-mediated apoptosis in colorectal cancer through ROS-dependent activation of IRE1α/JNK.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Endoplasmic Reticulum Stress; Endoribonucleases; Female; Humans; JNK Mitogen-Activated Protein Kinases; Mice, Inbred BALB C; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Xanthenes; Xenograft Model Antitumor Assays | 2020 |